Skip to the page

Data / Drug companies / Sanofi-Aventis U.S. LLC

Sanofi-Aventis U.S. LLC: 38 products in the FDA NDC directory, labeler code 0024

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sanofi-Aventis U.S. LLC (labeler code 0024) lists 38 products in the FDA National Drug Code Directory, covering 20 finished drugs by generic name. By type: 38 prescription drugs. Its main marketing category is biologics (BLA). The newest product started marketing on July 9, 2026.

The request: Watch Sanofi-Aventis U.S. LLC (FDA labeler code 0024): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0024
Products in commercial distribution
38
Packages
55
Finished drugs by generic name
20
Prescription products
38
Over the counter products
0
Flagged as original packager
38 of 38 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
November 17, 1997
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Biologics (BLA)2565.8%
New drug applications (NDA)1334.2%

Products by type

TypeProductsShare
Prescription drugs38100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Sarilumab41
Dupilumab41
Insulin lispro34
Irbesartan and hydrochlorothiazide215
Insulin glargine25
Sodium ferric gluconate complex21
Rasburicase21
Isatuximab21
Insulin aspart-szjj21
Irbesartan227
Ziv-aflibercept21
Clopidogrel213
Alirocumab22
Fexinidazole11
Dronedarone12
Plerixafor113
Isatuximab-irfc11
Insulin glargine and lixisenatide11
Cabazitaxel11
Primaquine phosphate15

Dosage forms

Dosage formProductsShare
Injection, solution2052.6%
Tablet, film coated821.1%
Kit37.9%
Injection25.3%
Injection, solution, concentrate25.3%
Solution, concentrate25.3%
Tablet12.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sarclisa Escena0024-0674Injection, solutionBiologics (BLA)July 9, 2026
Merilog0024-5928Injection, solutionBiologics (BLA)February 14, 2025
Merilog0024-5927Injection, solutionBiologics (BLA)February 14, 2025
Fexinidazole0024-4512TabletNew drug applications (NDA)July 16, 2021
Dupixent0024-5919Injection, solutionBiologics (BLA)June 14, 2021
Dupixent0024-5915Injection, solutionBiologics (BLA)June 19, 2020
Sarclisa0024-0656Injection, solution, concentrateBiologics (BLA)March 2, 2020
Sarclisa0024-0654Injection, solution, concentrateBiologics (BLA)March 2, 2020
Admelog0024-5926Injection, solutionBiologics (BLA)October 19, 2018
Dupixent0024-5918Injection, solutionBiologics (BLA)October 19, 2018
Admelog0024-5925Injection, solutionBiologics (BLA)December 11, 2017
Admelog0024-5924Injection, solutionBiologics (BLA)December 11, 2017
Kevzara0024-5922Injection, solutionBiologics (BLA)May 22, 2017
Kevzara0024-5920Injection, solutionBiologics (BLA)May 22, 2017
Kevzara0024-5910Injection, solutionBiologics (BLA)May 22, 2017
Kevzara0024-5908Injection, solutionBiologics (BLA)May 22, 2017
Dupixent0024-5914Injection, solutionBiologics (BLA)March 28, 2017
Soliqua 100/330024-5761Injection, solutionBiologics (BLA)November 21, 2016
Praluent0024-5902Injection, solutionBiologics (BLA)July 24, 2015
Praluent0024-5901Injection, solutionBiologics (BLA)July 24, 2015
TOUJEO Max0024-5871Injection, solutionBiologics (BLA)February 15, 2015
Toujeo0024-5869Injection, solutionBiologics (BLA)February 15, 2015
Ferrlecit0024-2794InjectionNew drug applications (NDA)July 7, 2014
Mozobil0024-5862Injection, solutionNew drug applications (NDA)September 1, 2013
Avalide0024-5856Tablet, film coatedNew drug applications (NDA)January 1, 2013

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.